Moreover, the effects of GEM are mediated by transporters to cross extracellular or intracellular membranes, and oncogenic mutations occurring in solute carrier (SLC) and the ATP-binding cassette (ABC) superfamilies also have been linked to drug resistance in pancreatic cancer [41]. Here, CCL21 is linked to pancreatic neoplasm.